313 related articles for article (PubMed ID: 24220314)
21. Dofetilide promotes repolarization abnormalities in perfused Guinea-pig heart.
Osadchii OE
Cardiovasc Drugs Ther; 2012 Dec; 26(6):489-500. PubMed ID: 22918600
[TBL] [Abstract][Full Text] [Related]
22. Impaired epicardial activation-repolarization coupling contributes to the proarrhythmic effects of hypokalaemia and dofetilide in guinea pig ventricles.
Osadchii OE
Acta Physiol (Oxf); 2014 May; 211(1):48-60. PubMed ID: 24533513
[TBL] [Abstract][Full Text] [Related]
23. Frequency dependent effects of tocainide, quinidine, and flecainide on conduction as reflected in the rise time of the monophasic action potential in the isolated guinea pig heart.
Duker BG
Cardiovasc Res; 1991 Mar; 25(3):217-22. PubMed ID: 1903081
[TBL] [Abstract][Full Text] [Related]
24. Detecting drug-induced prolongation of the QRS complex: new insights for cardiac safety assessment.
Cros C; Skinner M; Moors J; Lainee P; Valentin JP
Toxicol Appl Pharmacol; 2012 Dec; 265(2):200-8. PubMed ID: 23073507
[TBL] [Abstract][Full Text] [Related]
25. Electrophysiological determinants of arrhythmic susceptibility upon endocardial and epicardial pacing in guinea-pig heart.
Osadchii OE
Acta Physiol (Oxf); 2012 Aug; 205(4):494-506. PubMed ID: 22356273
[TBL] [Abstract][Full Text] [Related]
26. Arrhythmogenic drugs can amplify spatial heterogeneities in the electrical restitution in perfused guinea-pig heart: An evidence from assessments of monophasic action potential durations and JT intervals.
Osadchii OE
PLoS One; 2018; 13(1):e0191514. PubMed ID: 29352276
[TBL] [Abstract][Full Text] [Related]
27. Proarrhythmic actions of flecainide in an isolated tissue model of ischemia and reperfusion.
Heisler BE; Ferrier GR
J Pharmacol Exp Ther; 1996 Oct; 279(1):317-24. PubMed ID: 8859009
[TBL] [Abstract][Full Text] [Related]
28. Lack of selectivity for ventricular and ischaemic tissue limits the antiarrhythmic actions of lidocaine, quinidine and flecainide against ischaemia-induced arrhythmias.
Barrett TD; Hayes ES; Walker MJ
Eur J Pharmacol; 1995 Oct; 285(3):229-38. PubMed ID: 8575508
[TBL] [Abstract][Full Text] [Related]
29. Na+ channel distribution and electrophysiological heterogeneities in guinea pig ventricular wall.
Osadchii OE; Soltysinska E; Olesen SP
Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H989-1002. PubMed ID: 21186271
[TBL] [Abstract][Full Text] [Related]
30. Electrophysiological effects of sodium channel blockers on guinea pig left atrium.
Shirayama T; Inoue D; Inoue M; Tatsumi T; Yamahara Y; Asayama J; Katsume H; Nakagawa M
J Pharmacol Exp Ther; 1991 Nov; 259(2):884-93. PubMed ID: 1658312
[TBL] [Abstract][Full Text] [Related]
31. Electrocardiographic marker of the cardiac action potential triangulation induced by antiarrhythmic drugs in perfused guinea-pig heart.
Osadchii OE
Exp Physiol; 2022 Aug; 107(8):864-878. PubMed ID: 35561081
[TBL] [Abstract][Full Text] [Related]
32. Effects of ventricular pacing protocol on electrical restitution assessments in guinea-pig heart.
Osadchii OE
Exp Physiol; 2012 Jul; 97(7):807-21. PubMed ID: 22447974
[TBL] [Abstract][Full Text] [Related]
33. Refractory dispersion promotes conduction disturbance and arrhythmias in a Scn5a (+/-) mouse model.
Martin CA; Grace AA; Huang CL
Pflugers Arch; 2011 Oct; 462(4):495-504. PubMed ID: 21779762
[TBL] [Abstract][Full Text] [Related]
34. [Effects of quinidine on pinacidil-induced transmural dispersion of repolarization in canine right ventricular wall].
Luo J; Yang XC; Wang LF; Zhou P; Li CL; Wang MS; Gao Y; Wang LZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):369-71. PubMed ID: 15932676
[TBL] [Abstract][Full Text] [Related]
35. Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs.
Wu B; Sato T; Kiyosue T; Arita M
Cardiovasc Res; 1992 Nov; 26(11):1095-101. PubMed ID: 1291087
[TBL] [Abstract][Full Text] [Related]
36. Assessments of the QT/QRS restitution in perfused guinea-pig heart can discriminate safe and arrhythmogenic drugs.
Osadchii OE
J Pharmacol Toxicol Methods; 2017 Sep; 87():27-37. PubMed ID: 28552278
[TBL] [Abstract][Full Text] [Related]
37. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/- murine hearts modelling the Brugada syndrome.
Stokoe KS; Balasubramaniam R; Goddard CA; Colledge WH; Grace AA; Huang CL
J Physiol; 2007 May; 581(Pt 1):255-75. PubMed ID: 17303635
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms underlying increased right ventricular conduction sensitivity to flecainide challenge.
Veeraraghavan R; Poelzing S
Cardiovasc Res; 2008 Mar; 77(4):749-56. PubMed ID: 18056761
[TBL] [Abstract][Full Text] [Related]
39. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
Kreeger RW; Hammill SC
Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of quinidine, flecainide, and cibenzoline on anisotropic conduction in the isolated porcine heart.
Lacroix D; Delfaut P; Adamantidis M; Cardinal R; Klug D; Kacet S; Dupuis B
J Cardiovasc Electrophysiol; 1998 Jan; 9(1):55-69. PubMed ID: 9475578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
